His primary scientific interests are in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Virology and Cohort study. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Abacavir. His Immunology study frequently links to adjacent areas such as Risk factor.
His Acquired immunodeficiency syndrome research incorporates themes from Survival rate, Surgery, Disease and Pneumonia. His studies deal with areas such as Protease inhibitor, Antigen presentation and Antigen as well as Virology. His research in Cohort study intersects with topics in Relative risk, Mortality rate, Cohort and Comorbidity.
Jan Gerstoft mainly focuses on Internal medicine, Immunology, Virology, Acquired immunodeficiency syndrome and Cohort study. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Surgery. His study brings together the fields of Cytotoxic T cell and Immunology.
His biological study spans a wide range of topics, including RNA, Antibody, Drug resistance and Genotype. The Acquired immunodeficiency syndrome study which covers Viral disease that intersects with Immunopathology. The various areas that Jan Gerstoft examines in his Cohort study study include Mortality rate, Incidence, Pediatrics and Cohort.
Jan Gerstoft spends much of his time researching Internal medicine, Immunology, Gastroenterology, Viral load and Comorbidity. His study involves Hepatitis C, Cohort study, Randomized controlled trial, Regimen and Confidence interval, a branch of Internal medicine. His research integrates issues of Incidence, Pediatrics and Cohort in his study of Cohort study.
In the subject of general Immunology, his work in CD8 and T cell is often linked to Cart and Asymmetric dimethylarginine, thereby combining diverse domains of study. His research on Viral load concerns the broader Virology. In the field of Virology, his study on Neutralizing antibody overlaps with subjects such as Adenosine kinase.
His scientific interests lie mostly in Internal medicine, Immunology, Cohort study, Viral load and Gene. The Internal medicine study combines topics in areas such as Gastroenterology, Elbasvir and Grazoprevir. His Immunology research is multidisciplinary, relying on both Microbiome, Men who have sex with men and Incidence.
His study focuses on the intersection of Cohort study and fields such as Comorbidity with connections in the field of Gerontology, Cause of death, Proportional hazards model, Cohort and Acquired immunodeficiency syndrome. Jan Gerstoft has included themes like Hepatitis B vaccine, HBsAg, Hepatitis B virus, Unsafe Sex and Disease burden in his Viral load study. His Gene study combines topics in areas such as Virus, Cell culture and Mechanism of action.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
Alison J. Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza.
JAMA (2016)
Survival of Persons with and without HIV Infection in Denmark, 1995–2005
Nicolai Lohse;Ann-Brit Eg Hansen;Gitte Pedersen;Gitte Kronborg.
Annals of Internal Medicine (2007)
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus
Thomas N. Kledal;Mette M. Rosenkilde;Florence Coulin;Graham Simmons.
Science (1997)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin
Peter Garred;Hans O Madsen;Ulla Balslev;Bo Hofmann.
The Lancet (1997)
Mortality Attributable to Smoking Among HIV-1–Infected Individuals: A Nationwide, Population-Based Cohort Study
Marie Helleberg;Marie Helleberg;Shoaib Afzal;Gitte Kronborg;Carsten Schade Larsen.
Clinical Infectious Diseases (2013)
Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study
Hans-Jürgen Stellbrink;Chloe Orkin;Jose Ramon Arribas;Juliet Compston.
Clinical Infectious Diseases (2010)
Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study
Niels Obel;Henrik F. Thomsen;Gitte Kronborg;Carsten S. Larsen.
Clinical Infectious Diseases (2007)
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza.
The Lancet (2019)
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
Mark Sulkowski;Christophe Hezode;Jan Gerstoft;John M Vierling.
The Lancet (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Odense University Hospital
Statens Serum Institut
Rigshospitalet
Copenhagen University Hospital
University of Copenhagen
Copenhagen University Hospital
Aarhus University Hospital
University of Copenhagen
Copenhagen University Hospital
University College London
Korea University
LG (United States)
Johnson & Johnson (United States)
University of California, Irvine
John Innes Centre
National Academies of Sciences, Engineering, and Medicine
Landcare Research
University of California, Davis
University of Cologne
Emory University
National Institutes of Health
Grenoble Alpes University
Centre national de la recherche scientifique, CNRS
University of Copenhagen
Yale University
University of Oxford